Skip to content

Steroid-Skreen 35066422

by Biochemical Diagnostics Inc

Steroid-Skreen 35066422, a 17-Hydroxycorticoid IVD (FDA Class I; FDA product code CDB, Porter Silber Hydrazone, 17-Hydroxycorticosteroids) made by Biochemical Diagnostics Inc, was listed in FDA GUDID on 30 Apr 2020 (UDI-DI 00810042682177); the registry lists it as not in commercial distribution (GUDID) as of 22 Oct 2026.

Listed FDA GUDID listing, not in commercial distribution

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00810042682177 UDI-DI Date30 Apr 2020ListedStatusListed GUDID: not in commercial distribution

Official records

From the FDA record

Device description
ELUTION SOLVENT, 80% Ethanol, 4L
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Steroid-Skreen
Generic name
17-Hydroxycorticoid IVD, reagent
Model / Ref / Catalog
35066422
Primary DI / UDI-DI
00810042682177
FDA product code
CDB
GMDN term
17-Hydroxycorticoid IVD, reagent
Device class
Class I
Regulation number
862.1385
GUDID distribution status
Not in Commercial Distribution

Other devices from Biochemical Diagnostics Inc

See all devices from Biochemical Diagnostics Inc →

Properties

  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)